News

Dr. Tracy Stevens shares how heart disease affects women uniquely and why more advocacy and research is needed on women's hearts.

Saint Luke’s has been delivering babies for 135 years. To honor this anniversary, we are taking a look back at Kansas City through the decades.

This award recognizes hospitals for their efforts toward care excellence for suspected non ST-elevation acute coronary syndrome care excellence.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

The groundbreaking STEP-HFpEF study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named one of the top advances by the American Heart Association.

A groundbreaking study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named the scientific breakthrough of the year by Science Magazine.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

AARP talked to Dr. James O'Keefe about the benefits of omega fatty acids and how much you should be consuming.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

A growing body of evidence correlates shorter running sessions to significant health benefits, especially those regarding longevity and mental health.